Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
10.5468/ogs.2020.63.2.150
- Author:
Semiramis L CARBAJAL-MAMANI
1
;
David SCHWEER
;
Merry J MARKHAM
;
Ashwini K ESNAKULA
;
Joseph R GRAJO
;
Jacqueline C CASTAGNO
;
Joel CARDENAS-GOICOECHEA
Author Information
1. Department of Medicine, College of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
- Publication Type:Original Article
- Keywords:
Robotic surgical procedure;
Ovarian cancer;
Cytoreductive surgical procedure
- From:Obstetrics & Gynecology Science
2020;63(2):150-157
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine the perioperative outcomes.METHODS: A retrospective study of 12 patients with stage IIIC or IV ovarian, fallopian tube, and primary peritoneal carcinoma who underwent interval cytoreductive surgery after neo-adjuvant chemotherapy.RESULTS: Optimal cytoreduction was achieved in 100% of selected patients. Complete cytoreductive surgery was achieved in 75% of patients. The estimated mean blood loss was 100 mL. The median length of hospital stay was 2 days. Perioperative complication and 30-day readmission rates were 8.3% (1 patient). The median follow-up time was 9.5 months.CONCLUSION: Robotic-assisted interval cytoreductive surgery in ovarian cancer is safe and feasible and may be an alternative to standard laparotomy in selected patients.
